Zimbabwe faces LCIA claim over covid-19 testing kits
Zimbabwe’s state-owned pharmaceutical company has been threatened with an LCIA claim over the termination of a US$60 million contract to supply covid-19 testing kits, amid a criminal investigation that has led to charges against the country’s former health minister.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10